Notable News Archives

June 2020 Notable News

It’s officially summer so grab a cup of coffee and soak up some vitamin D because this month we learn that both of those things can help prevent cancer. We also learn about the recall of a popular drug and the approval of some others. In addition, there’s a new blood test to diagnose liver cancer and some tips on how to recognize skin cancer. Finally, research shows that COVID-19 remains a very real threat, especially for cancer patients.

Vitamin D and Coffee Benefits

With so much going on, your vitamin D status may not be on your mind, but you might want to give it some thought, reports sciencedaily.com. It turns out that a good vitamin D status is good for cancer prevention and prognosis, especially for colon and blood cancers like leukemia and lymphoma. Conversely, a low vitamin D status often correlates with higher incidence of cancer and lower survival rates. You can learn more about vitamin D and cancer here.

While you’re out soaking up the vitamin D from the sun’s rays, you might want to bring your favorite cup of coffee because there’s evidence that coffee could reduce the risk of cancer, reports dailycoffeenews.com. The news comes from an update in the diet activity guidelines from the American Cancer Society. It’s not known how or why coffee seems to help prevent several types of cancers, but there’s been a decade of research that supports the claim. In addition to coffee, the American Cancer Society recommends following a healthy diet, limiting alcohol, staying active, and maintaining a healthy weight. Research shows that diet and exercise lifestyle choices are connected to 18 percent of all cancer cases in the United States. Learn more about coffee and cancer here.

Take a Look at Your Skin

All this talk about sun exposure makes it a good time to think about skin cancer. Especially since there’s room for improvement in skin cancer survival rates, says consumerreports.org. Getting to know your own skin could be the key to survival. A Consumer Reports survey found that only 52 percent of Americans have their skin regularly checked by a doctor. There’s debate about whether or not everyone should see a dermatologist every year, but early detection of skin cancer makes a big difference. When skin cancer is found early treatment is relatively non-invasive and early stage melanoma has a 98 percent survival rate. So, whether you see a doctor or not, you should perform monthly skin checks of your own. Get familiar with the moles and marks on your skin and look for any that don’t seem to fit in. If you find something that looks irregular, let your doctor know. Learn more and find examples of what skin cancer looks like here.

Metformin Hydrochloride Recall

While you’re checking your skin, you might also need to check your list of medications. A popular diabetes drug has been recalled due to cancer risk, reports webmd.com. All lots of metformin hydrochloride extended release 500 mg tablets were recalled due to the possibility that they contained high levels of N-Nitrosodimethylamine (NDMA) which is a chemical thought to cause cancer. A test by the United States Food and Drug Administration (FDA) found higher than allowed levels of NDMA in one lot of metformin. Get more information about the recall here.

FDA Expands Indication for Gardasil 9

The FDA has given accelerated approval for the use of a vaccine to prevent head and neck cancers, reports statnews.com. The human papilloma virus (HPV) vaccine, Gardasil 9, is recommended for both males and females ages 9 through 45 to prevent several cancers. However, the vaccine was not previously recommended as prevention for head and neck cancers even though they are commonly caused by HPV in the United States. The hope is that, by including head and neck cancers in the list of cancers the vaccine prevents, it will raise awareness for and help prevent the occurrence of these types of cancers. Find more about Gardasil here.

Good News for Thyroid and Non-Small Cell Lung Cancer

The FDA has also given accelerated approval for a drug to treat thyroid and lung cancer, says cancer.gov. The drug selpercatinib (Retevmo) will treat people with thyroid or non-small cell lung cancer with tumors that have a gene alteration called RET. The drug blocks the RET proteins and was shown to shrink tumors. Selpercatinib has fewer side effects than older RET blocking drugs. Accelerated approval means that, although the drug has not gone through all required levels of testing, it can be approved for use, but testing must continue while the product is on the market. The process is only used for drugs that treat serious or life-threatening diseases without better treatment options. Learn more about the accelerated approval of selpercatinib here.

Combatting Nausea

There’s another drug of note this month giving hope to advanced cancer patients who have nausea and vomiting, says cancer.gov. In a study conducted by the National Cancer Institute the drug olanzapine (Zyprexa) was found to reduce nausea and vomiting in advanced cancer patients. Olanzapine is an antipsychotic medication mainly used to treat bipolar disorder and schizophrenia and has also been used off-label to prevent nausea and vomiting in cancer patients. Learn more here.

Detecting Liver Cancer

The National Cancer Institute was also involved in a study where a blood test has been developed to determine which people are most likely to develop liver cancer, says cancer.gov. The simple blood test is used to check for exposure to certain viruses that lead to the development of hepatocellular carcinoma (HCC) which is the most common form of liver cancer. The test could help lead to early diagnosis and treatment. Most patients with HCC are diagnosed when the cancer is advanced and incurable, but when caught early the prognosis is much better. With HCC on the rise in the US, a test that could help with early detection is welcome news. Learn more about the testing here.

COVID-19 Update

The not-so-welcome news continues about the novel coronavirus. There are some new studies that emphasize the danger of the coronavirus for cancer patients, reports apnews.com. The studies showed that current and former cancer patients who developed COVID-19 were more likely to die within a month than people without cancer. One study showed that 13 percent of cancer patients with COVID-19 died. Another study found the death rate to be 28 percent. The studies are a reminder of how critical it is for cancer patients to do all they can to follow safety guidelines so they can avoid contracting the virus. Find out more here.

Notable News: May 2020

Just in time for summer, there are a couple of compelling reminders of why we should all be exercising more. There’s also a new map for breast cancer, and a new vaccine that we’ve all been hoping for. No, not the one for Covid-19, but this one is equally important. Oh, and, speaking of infectious diseases, new research shows that getting an infectious disease could very possibly lead to cancer.

Researchers have found a link between infectious diseases and the development of cancer, reports medicalnewstoday.com. In a study that looked at data from more than 50,000 people over a period of seven years, researchers determined that people who had had an infectious disease, such as influenza, pneumonia, gastroenteritis, and hepatitis, had a higher risk of developing a later cancer. In addition, different infections were linked to different forms of cancer. For example, people who had pneumonia were more likely to later develop stomach cancer. More research needs to be done to fully understand the connection but, knowing that there is a link between some diseases and future cancer occurrence could help in developing better cancer screenings and diagnostic testing. It could also help us all work harder at staying as healthy as possible. Learn more here.

Like it or not, a great way to actively try to stay healthy is through exercise. Research continues to show that exercise is beneficial for cancer treatment and prevention. More specifically, a new study shows that exercise may help prevent liver cancer, reports medicalnewstoday.com. This is particularly good news because liver cancer is on the rise and it is deadly. The general five-year survival rate is 18 percent. Men are at a higher risk of developing liver cancer, and it is the fastest growing cause of cancer death for men in the United States. The study, performed on mice, found that exercise reduced the occurrence of liver cancer. While all the mice in the study were obese, only 15 percent of the mice who exercised developed liver cancer. Of the mice that didn’t exercise, 64 percent developed liver cancer. In addition to establishing the link between exercise and liver health, the researchers also discovered molecular reasons why exercise may prevent liver cancer. They found that exercise switched off a stress-activated protein that has been found to support tumor development and turned on a gene that has been found to inhibit the growth of cancer cells. Hop on the treadmill and learn more about the study here.

Exercise can not only prevent cancer, it can also increase your chance of survival. A new study shows that exercise increases the length of survival for women with high-risk breast cancers, reports cancer.gov. High-risk breast cancers are more likely to recur or spread, but the study showed that women who were physically active were more likely to live longer and were less likely to have their cancer recur. While those who exercised the most and the most often showed a greater reduction in rates of recurrence and chance of death, there were positive outcomes for those who exercised during any stage of their diagnosis and treatment. Learn more about the positive effect exercise can have on breast cancer survival rates here.

There’s encouraging news in breast cancer prevention as well. A new guide has been developed to show how environmental toxins can lead to breast cancer, reports medicalxpress.com. Since only five to ten percent of breast cancers are a result of high-risk, inherited gene mutations, researchers wanted to better understand the role toxic chemicals play in the development of breast cancer. Using radiation exposure as a model, researchers identified the sequential biological changes that occur through exposure to toxic chemicals. The information was used to create a map highlighting the various ways toxins can lead to breast cancer. Researchers hope their map will be used in the development and regulation of chemicals. Knowing which chemicals can trigger breast cancer could help in reducing the number of breast cancer cases. More information can be found here.

Of course, the ultimate form of cancer prevention might be a vaccine and researchers are getting closer to making that a reality. A new and promising cancer vaccine has been developed, reports techtimes.com and medicalxpress.com. The vaccine was developed using microcapsules and when the vaccine is injected, the microcapsules, which have a self-healing component, activate the immune system, and inhibit tumor development. The vaccine showed effectiveness against different types of tumors including melanoma, breast cancer, and lymphoma. More information about how the vaccine was developed and how it works in the body can be found here and here.

It’s nice to know that the scientists are out there doing the research and working on creating important vaccines that give us hope for a healthier tomorrow, but it’s also nice to know that simply by taking a walk or a run or a bike ride and by washing our hands or wearing a mask or keeping our distance, we are all taking important steps toward being empowered patients today.

Notable News – April 2020

The novel coronavirus continues to dominate the news and affect just about everyone, but it’s not the only news this month. There’s a newly approved drug to treat breast cancer, some pretty cool bacteria in your gut, and a potential way to turn off cancer. We’ll get to all the good stuff but, we can’t ignore the coronavirus because it’s changing the way we treat cancer, so let’s start there.

While there is some evidence that our social distancing efforts are helping to slow the spread of the coronavirus that has plagued the globe for the better part of 2020, the threat of Covid-19 is still very real, and it is affecting how cancer patients are being treated, reports fredhutch.org. Many patients are finding that their treatments are being delayed, rescheduled, or put off altogether. The idea is to protect cancer patients, who are at higher risk for complications from Covid-19, from contracting the virus. That means keeping them out of emergency rooms and treatments centers. In addition, medical resources such as ventilators, masks, and gowns, and even time in the operating room, are in short supply so patients with less aggressive cancers may find that their surgeries are being delayed in order to lessen the burden on the supply. For many patients, the delay or change in treatment is safe, but for some patients, a delay in treatment could decrease their survival rate. Determining how to treat cancer patients during this global pandemic is difficult for doctors because the risks and the stakes are so high. Fortunately, adjustments are being made to cancer treatment guidelines so patients can continue to be safely treated. Wider usage of telehealth and drugs that can boost white blood cell counts during chemo, and screening patients for symptoms before allowing them into treatment centers are among the new procedures. Learn more about how Covid-19 is affecting how cancer is being treated here.

Another result of Covid-19 is the early release of a drug to treat breast cancers. This month, the United States Food and Drug Administration (FDA) approved the drug Tukysa, or tucatinib, to be used in combination with chemotherapy to fight aggressive forms of breast cancer, reports geekwire.com. “We recognize that patients with cancer constitute a vulnerable population at risk of contracting the coronavirus disease,” Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Office of Oncologic Diseases in the FDA’s Center for Drug Evaluation and Research, stated in a news release from the FDA. “In this critical time, we remain steadfast in our commitment to patients with cancer and doing everything we can to expedite oncology product development. Tukysa was approved four months prior to the FDA goal date, providing an example of this commitment and showing how our regular work in reviewing treatments for patients with cancer is moving forward without delay.” The drug will be used to treat adult patients with HER2 positive breast cancer that cannot be surgically removed and that has metastasized. HER2 positive breast cancer metastasizes to the brain in more than 25 percent of patients. Tucatinib targets the HER2 receptor and is taken as a daily pill. The drug costs an average of $111,000 per patient. More information can be found here and you can read the FDA’s news release about tucatinib here.

Thinking about the coronavirus might have everyone feeling a little bit queasy, but this news about gut bacteria might make you feel better. The communities of bacteria that live in your gut, the gut microbiota, might help treat cancer, says medicalnewstoday.com. A new study has shown that certain gut bacteria called Bifidobacterium can get inside tumors in the gut, activate the immune system, and improve the effectiveness of a cancer treating immunotherapy called CD47 blockade immunotherapy. The study performed on mice showed that the treatment worked better for mice with high levels of Bifidobacterium than it did for the mice without. This research could provide insight into why some patients respond better to immunotherapy than others and could lead to more effective immunotherapy treatments. Find more information about the study here.

We may all be wishing for an off switch for the coronavirus right now, but there may actually be one for cancer. Researchers have found a specific site where they can potentially stop the growth of many types of cancer, reports medicalxpress.com. For some time, scientists have known about molecules that interact with tumor suppressor proteins, called PP2A. The PP2A proteins act as an off switch for cancer and stop its growth. However, scientists didn’t know where the molecules interacted with the PP2A proteins, so they couldn’t use the information to make cancer-treating drugs. Using cryo-electron microscopy to get 3D images of where the molecule is bound to the PP2A proteins they could see how the different parts of the protein were brought together. The new information is a step toward developing drugs that could activate these tumor suppressor proteins. PP2A proteins may also be helpful in treating cardiovascular and neurodegenerative diseases like heart failure and Alzheimer’s. Get more information here.

Hopefully, the coronavirus off switch will be developed soon, but in the meantime, stay safe and stay tuned next month for more Notable News.

Notable News January 2020

From our own immune systems to turmeric, researchers are searching just about everywhere to help put a stop to cancer. The possibilities are endless and the advancements are remarkable. A new treatment or a cure could be anywhere. And, acupuncture can help, too!

It turns out that acupuncture could be the solution to a particularly troublesome and painful side effect from chemotherapy, reports bbc.com. In a patient study, acupuncture was found to relieve chemotherapy neuropathy, which is nerve damage, usually in the hands and feet, that causes tingling, numbness, and other symptoms. More severe cases can be very painful and affect a patient’s quality of life. The three year study of 120 patients showed that, with regular acupuncture treatment, patients found relief from the pain of neuropathy. Learn more here.

Of course, chemotherapy and its side effects might eventually fade into the past. It’s looking more and more like a cure to cancer might very well be inside each of us. Scientists have found a T-cell in our immune systems that can check the body for cancer cells, attack and kill them, and leave the healthy cells alone, reports BBC.com. The discovery was made by British scientists while they were analyzing blood for immune cells that could fight bacteria, says theblaze.com. Instead, they discovered a T-cell that can attack many different cancers, including lung, skin, blood, colon, breast, bone, prostate, ovarian, kidney, and cervical cancers. The study findings suggest that one therapy could be developed to treat all cancers, which is different than the current and very specific immunotherapies. Treatment would involve taking a blood sample from the patient, extracting, modifying, and producing more of the T-cells, and then putting the newly modified T-cells back in the patient to seek out and destroy the cancerous cells. So far the research has been tested on animals and is not yet ready for human testing, but the researchers hope to be able to test the treatment in patients by the end of the year. You can learn more here, and here, and even more here.

Also new in cancer treatment is a medication providing hope for acute myeloid leukemia (AML) patients, notes cancer.gov. The drug, CC-486, is a pill that patients can take at home (as opposed to AML therapy, azacitidine, which is an injection or infusion that is given at the doctor’s office or hospital), and it is the first AML maintenance therapy that extends remission and shows an increase in patient survival. CC-486 was tested in a clinical trial of almost 500 AML patients, age 55 or older. The study found that the patients who took CC-486 survived 10 months longer than those who did not take it, and the pill also extended how long the patients stayed in remission. More studies of CC-486 are being done to determine how it might best be used to transform the treatment of AML in the future. Find out more here.

While new therapies are being discovered, there are also some new cancer fighting drugs that aren’t so new at all, reports medicalxpress.com. Researchers discovered about 50 already-existing drugs, used to treat conditions such as diabetes, inflammation, and high cholesterol, that also have cancer fighting properties. To identify which already circulating medications might be able to be used to treat cancer, researchers used a drug hub that contains more than 6,000 drugs which are FDA-approved or proven safe through clinical trials. The findings determined that the medications killed cancer cells in ways that most cancer drugs typically don’t. Existing cancer drugs tend to block proteins to be effective against the cancer cells, but the non-oncology drugs that were tested worked against the cancer cells by activating or stabilizing proteins. The researchers are continuing to analyze their data and have shared it openly with the rest of the scientific community. Find more information here.

Some other potential cancer fighters that already exist include salt, turmeric, and bitter melon, reports medicalnewstoday.com. Information about a new study where salt has been successfully used to kill cancer cells can be found here. Between 1924 and 2018 there have been 12,595 papers studying the healing properties of turmeric and 37 percent of those have focused on cancer. Learn more about whether or not turmeric is a viable option for treating cancer here. There is also a study that shows that bitter melon, a traditional Indian remedy, might be effective in preventing the spread of cancer. Read more about that study here.

Whether the study is about immunotherapy or salt, all the research suggests the same thing: until we can put a stop to cancer, researchers will never stop searching for a cure.

Notable News: December 2019

While 2019 is nearing its end, there are all kinds of new beginnings in cancer research. Scientists are finding new and exciting discoveries that could lead to fine-tuned cancer treatments specific to each person, each type of cancer, and each response the body has to treatment. Using tropical flowers, mitochondria, and an off switch for cells, researchers keep finding new paths to treatment for even the most difficult and deadly cancers. Of course, that doesn’t mean we need to forget about prevention; there continues to be new information about how our lifestyles could affect our cancer risk, right down to our hair color.

A trip to the hair salon might mean an increased cancer risk, reports ecowatch.com. A study by the National Institutes of Health shows that permanent hair dyes and chemical hair straighteners might put women at an increased risk for cancer. The study found that women who used permanent hair color were nine percent more likely to get breast cancer. Black women, though less likely to use hair dye, had the most notable risk. They showed a 45 percent higher risk of developing breast cancer. Women who used hair straighteners had an 18 percent higher risk of breast cancer. Frequency of use posed a problem, too. Hair products can contain more than 5,000 chemicals, including formaldehyde, which is a known carcinogen. This study’s findings aren’t enough to draw a definitive link between the hair products and breast cancer, and no warnings have been issued about using hair products, but the findings do indicate that more research needs to be done to determine whether or not there is a connection. Read more about this study here.

Wouldn’t it be great if you could just switch off a cell to prevent tumors from growing and spreading? It might be possible, reports medicalxpress.com. Researchers have discovered what could be a new cancer immunotherapy treatment for patients who haven’t responded to other types of immunotherapy. The study, done on mice, shows that many tumors display the molecule MR1, which keeps the body from fighting the cancer cells. Researchers found that when they gave the mice an antibody that blocked the MR1 cell, cancer fighting cells could come in to slow cancer growth and prevent it from spreading. With this new information, doctors would be able to screen patients to see if they have the MR1 cell, and determine if they would respond to the potential new immunotherapy. Researchers now want to apply what they’ve learned to human tumors. You can learn more about the findings here.

Another treatment-related discovery is that there might be an alarm at the molecular level that serves as an alert when cancers have become resistant to treatment, reports sciencedaily.com. Mitochondria, which are present in most cells, can sense DNA stress which can indicate when cancer cells have developed resistance to chemotherapy, researchers found. The findings could lead to new cancer treatments that would prevent chemotherapy resistance, making it more effective. See the details about this discovery here.

Also from sciencedaily.com, we’ve learned that a tropical flower might hold the answer to treating pancreatic cancer. The plant, Uvaria Grandiflora, grows in Malaysia, Indonesia, Thailand, and the Philippines, and its flower contains a chemical that researchers have used as a model to create three new molecules which they hope could treat pancreatic cancer. All three of the molecules have shown that they kill pancreatic cancer cells in a Petri dish, and while the potential drug trials are more than five years away, these molecules could become new drugs for treating pancreatic cancer that would be more effective and less toxic than current treatments. You can find more information here.

As you say goodbye to 2019, we hope you will continue to say hello to Patient Empowerment Network. We will continue to provide you the latest in cancer research news as we continue in our mission to empower patients, family members, and caregivers in innovative ways. We’re particularly proud of our digital sherpa™ program, which you can learn more about at voice.ons.org. Learn how the sherpas are used to enhance the experience of patients and nurses as told by Regina White, RN, MS, OCN at Moffitt Cancer Center in Tampa, Florida. Check it out here.

Happy, Healthy, New Year to all!

Notable News July 2019

So much for the dog days of Summer. July was a super active Notable News month full of information. There are risks and recalls to be aware of, along with some very encouraging news about exciting new research and treatments. So, while you may not want to hear that you should probably consider getting a colonoscopy ASAP, you’ll be relieved to learn that some cancers may have much less invasive diagnostic tools on the horizon. Oh, and there are a couple links to some really interesting (although alarming) longer reads; just in case you’re embracing the dog days, and need some reading material, this summer.

Increased Cancer Risk

Colon cancer is on the rise for people younger than 50, reports cbsnews.com. The rate has increased over the past decade from 10 percent of all cases to about 12 percent. While there is no concrete explanation as to why colon cancer is increasing among the younger age group, one possibility is that it is linked to modern diets and the gut microbiome. Conversely, colon cancer rates are declining among those 50 and older, largely because of colonoscopy screenings which detect polyps before they become cancerous. Find out more below.

Breast implants that have been linked to cancer are being recalled, according to nytimes.com. The textured implants were banned in Europe late last year and are now being recalled in the United States by the Food and Drug Administration (FDA). The implants are linked to anaplastic large-cell lymphoma. It is a rare cancer of the immune system that develops in the tissue around the implant. Removing the implant and scar tissue around it is effective in curing the cancer in most cases, but if it is not found early it can spread and be deadly. Symptoms are swelling and fluid around the implant, and patients should have symptoms checked by their doctor. More information about the implants can be found below.

There is a link between radioactive iodine (RAI) treatment and cancer deaths, says cancer.gov. RAI has been commonly used to treat hyperthyroidism since the 1940s. An association between the dose of RAI treatment and long-term risk of death from cancers, including breast cancer, has been found in a study led by researchers at the National Cancer Institute. More research is needed to better understand the risks and the benefits of the treatments, but in the meantime, the information will help patients discuss hyperthyroid treatment options with their doctors. More information about the research can be found below.

Treatment and Detection

Immunotherapy may work in treating brain cancer, says medicalxpress.com. Researchers have found a way to make the CAR T immune therapy more effective against glioblastoma, the most common and most deadly form of brain cancer. Previous research showed that not all of the tumors could be targeted by the T cells. So, in order to more strategically target the tumors, researchers used a bi-specific T-cell engager, or “BiTE”, that makes it possible for CAR T cancer-killing cells to be sent to specific targets, making the treatment more effective. Learn more about the complicated, but promising, process below.

There may be a better, non-invasive way to detect bladder cancer, reports medicalnewstoday.com. Researchers in Spain have proposed using electronic tongues. The devices can detect or “taste” soluble compounds by using software and sensors. The tongues, used to analyze food, water, wine, and explosives, can also be used to detect diseases by testing samples of biofluid. Using the tongues to test urine samples could be an easy and inexpensive way to detect bladder cancer in the early stages. Learn more about the proposed tongue testing below.

Researchers may have found a new way to treat ovarian cancer, according to medicalnewstoday.com. Researchers have identified an enzyme known as IDH1 that encourages the growth of high-grade serous ovarian cancer, the most common form of ovarian cancer. The cancer is difficult to detect in early stages and hard to treat because it often develops a resistance to chemotherapy. Researchers found that when they blocked the IDH1 enzyme, the cancer cells were unable to divide and grow. The research also suggests that blocking the enzyme works on the cancer cells that have spread to other parts of the body as well as where the cancer originated. More information about this encouraging research can be found below.

Cancer-Causing Toxins

If you’ve never heard of ethylene oxide, you might want to consider reading the article ‘Residents Unaware of Cancer-Causing Toxins in Air’ from webmd.com. Ethylene oxide is an invisible chemical with no noticeable odor. It is used to sterilize medical equipment and make antifreeze, and it is on the EPA’s list of chemicals that definitely cause cancer. It is also an airborne toxin in areas that have been flagged as high-cancer risk, but many of the residents of those areas have no idea they are being exposed.

Another article worth reading this month can be found at huffpost.com. A new plastics plant is planning to come to an area in the middle of Louisiana’s “Cancer Alley”, and the residents, tired of cancer-causing chemical pollutants, are fighting back. Read about their path to empowerment below.


Resource Links:

cbsnews.com

Colon Cancer Study Finds Colon Cancer Rates Rising for Patients Under 50

nytimes.com

Breast Implants Linked to Rare Cancer Are Recalled Worldwide

cancer.gov

NCI study finds long-term increased risk of cancer death following common treatment for hyperthyroidism

medicalxpress.com

Immune therapy takes a ‘BiTE’ out of brain cancer

medicalnewstoday.com

‘Electronic tongues’ may help diagnose early stage bladder cancer

Could targeting this enzyme halt ovarian cancer?

webmd.com

Residents Unaware of Cancer-Causing Toxin in Air

huffpost.com

A Community In America’s ‘Cancer Alley’ Fights For Its Life Against A Plastics Plant

Notable News – June 2019

It’s official! The nation’s cancer mortality rate continues to decline, says cancer.gov. The finding was revealed in this year’s annual report regarding the status of cancer in the country. The report shows that cancer death rates have continued to decline in men, women, and children from 1999 to 2016. Specifically, lung, bladder, and larynx cancers are decreasing, which is attributed to the decline in tobacco use. Conversely, cancers related to obesity are increasing. The highest overall cancer incidence rates occurred in black men and white women. The lowest rates were among Asian/Pacific Islander men and women. In addition, researchers looked specifically at cancer trends among those aged 20 to 49. In this group women had higher cancer and death rates than men, which is the opposite of the data among all age groups. Breast cancer, thyroid cancer, and melanoma were identified as the most common cancers on the rise among 20 to 49 year old women. The report, published last month in the Journal of the National Cancer Institute, is put together by the National Cancer Institute (NCI), the Centers for Disease Control and Prevention (CDC), the American Cancer Society (ACS), and the North American Association of Central Registries (NAACCR). Find more detailed information about the annual report here.

The decline in cancer deaths just may have a lot to do with the amazing strides being made in understanding cancer and its risk factors, ways to diagnose it, and ways to treat it. Researchers at Yale have made a discovery about how metastasis, the spread of cancer, occurs on the molecular level that could lead to new ways of treating cancer, reports medicalexpress.com. While the study focused on renal cancer, understanding metastasis on the molecular level could lead to new testing and treatment for all types of cancer. Find more information about the study and the metastasis process here.

It’s important to know if you are at risk for certain cancers and having children through IVF may be one of them, reports thesun.co.uk. A 21-year study analyzing over 600,000 Danish women suggests that women who have had children using IVF are more likely to develop breast cancer. In addition, women who had their first child through IVF when they were 40 or older, were 65 percent more likely to develop breast cancer than women of the same age who conceived naturally. The drugs given to women during IVF to stimulate the ovaries may be the culprit. They increase levels of estrogen, a known factor in the occurrence of breast cancer. Make sure you are staying on top of your breast cancer screenings if you had children using IVF, and learn more about the study here.

Also reported by thesun.co.uk, is good news about early detection, specifically for prostate cancer. Scientists have developed a simple urine test that could show signs of prostate cancer five years early. The test, which could be available in as few as five years, looks for changes in specific genes. If the changes are noted, further testing is done. The process would mean that some men would not have to have invasive testing procedures and others would know of their prostate cancer risk earlier. Learn more about the promising new test here.

Finally, of interest this month is an article by theatlantic.com regarding the two technologies that are changing the future of cancer treatment, and the way in which oncologists are looking at treating the disease. The article points to immunotherapy and CAR T-cell therapy as kindler, gentler approaches to cancer treatment. Chemotherapy, which is the most successful treatment to date, as the article points out, can make the treatment process brutal. Oncologists are turning to the new therapies to treat cancer without the harsh side effects that come with chemo. The article is a quick read and it provides hope for anyone who is or may be affected by cancer. That means all of us. Check it out here.

Notable News May 2019

Moving into summertime, for many, means increased sun exposure, so it’s pretty good timing that May, the gateway month to summer, is Skin Cancer Awareness Month. Prevention guidelines can be found at skincancer.org and include staying in the shade, avoiding tanning, and protecting your skin with clothing and sunscreen. More guidelines and tips can be found here. However, as noted in washingtonpost.com, prevention guidelines aren’t exactly universal. It turns out that sunscreen is not effective in preventing melanoma in darker-skinned people. While melanoma is a risk for all skin types, those with dark skin or of African descent, usually develop melanoma known as acral lentiginous melanomas which develops in parts of the body that don’t get much sun exposure, such as the palms of the hands or the soles of the feet. Of course, sunscreen use is still recommended for people with all skin types to prevent other sun-related damage, and it’s important to talk to your skincare professional about whether or not sunscreen is the best prevention option for you. Find out more here.

Summertime also tends to include barbecues and picnics, but you might want to think twice about what food you’re packing for the potluck, according to a new study reported in livescience.com. The study researchers estimated that more than 80,000 U.S. cancer cases diagnosed each year might be related to an unhealthy diet. The diets known to be related to cancer risk are low in whole grains, dairy, fruits, and vegetables, and high in processed meats, red meats, and sugary drinks. The cancers most closely-related to diet were colorectal, cancers of the mouth, pharynx and larynx, uterine cancer, and postmenopausal breast cancer. Adults ages 45 to 64 had the highest rate of diet-related cancer. More information about the study can be found here.

There is also increasing evidence that diet can help with cancer treatment, says theatlantic.com. Doctors are starting to look at how the food we eat could affect the cancer cells in our bodies and how what we eat may assist in treatment or preventing cancer cells from growing. Of course, because cancer is a very varied disease, there is no one diet that is best. Different nutrients, or the absence of them, affect different cancers in different ways. The promise is that doctors are starting to uncover the relationship between foods and cancers and how we can best utilize our diets for good health. More information can be found here.

In addition, straitstimes.com further explores the relationship with food and cancer. Researchers in Singapore found a link between a nutrient known as methionine, often in meat, fish and dairy products, and cancer. They discovered that cancer stem cells use methionine as fuel, but when they “starved” lung cancer cells of methionine for 48 hours, they saw a 94 percent reduction in the size of the tumors. The information is promising for the future of cancer treatment. More information can be found here.

No matter what is in your picnic basket or what kind of sunscreen you use, you can enjoy your summer with the knowledge that you are doing your part in being a hero in your own story — much like a young super hero named Wyatt who, during his fourth round of chemo, learned that his dreams would come true in a music video that involved fast cars, battling the bad guys, and pizza. It’s a feel-good story that feels just right for summer. You can read all about Wyatt here. It’s guaranteed to put a smile on your face as bright as the summer sun.

Notable News | April 2019

You may want to do some yoga, especially if you are experiencing chronic stress. However, you can breath a sigh of relief about the positive research in bladder and prostate cancers reported this month. There’s even some super cool research that involves containing, rather than killing, cancer cells. Check it out.

Chronic stress is not good for anybody, but as livescience.com reports, it may be even more detrimental for cancer patients. Acute stress is normal on occasion to help us avoid danger, but chronic stress, which weakens the immune system, leads to changes in the body that could then lead to the development and progression of cancer. However, experts say we can’t be so fast to draw a link between stress and cancer because of the ways different people respond to stress. Some people are motivated by it; others sickened by it. Some experts believe it may not be the stress that leads to cancer, but rather the poor habits people adopt to cope with stress. While experts don’t yet agree that there is a clear and definitive line between chronic stress and cancer, there is evidence that taking measures to reduce stress is best for overall health. Find out more here.

Speaking of stress, cancer can be stressful. Many patients turn to alternative forms of healing to manage the affects of cancer or treatment, but medicalnewstoday.com says, that may be doing more harm than good. As many as one third of people living with cancer are using alternative or complementary therapies. The most common form of alternative therapies is the use of herbal supplements, which researchers found could be a problem because the ingredients of herbal supplements are not always known, and there is a concern that supplement ingredients could negatively interact with the medicines they are taking. For example, high levels of antioxidants may make radiation less effective. Yoga, however, is the one complementary method of treatment that seemed to help patients. You can learn more about the research involving alternative and complementary therapies here, and decide whether or not those methods are right for you.

Researchers are starting to decide that maybe killing all the cancer cells isn’t the best option for combating cancer, reports medicalnewstoday.com. Cancer cells evolve really fast, and some studies show that there is no way of killing them all. Researchers are looking at a new approach of treating cancer that involves preventing it from developing and spreading by containing it. They hope to use medication to make the cancer cells dormant and keep them that way, which could be useful in cancers, such as breast cancer, which is now considered a chronic cancer because it can come back many years later with secondary tumors. You can learn more about this unique approach here.

Other findings this month bring good news for bladder cancer patients, reports seekingalpha.com. The FDA has approved the Johnson & Johnson drug, Balversa, for patients with metastatic bladder cancer. The approval was based on a trial that resulted in a 32 percent overall response rate. The patients who are eligible for Balversa, have metastatic bladder cancer with specific genetic alterations, but there is hope that it will eventually be tested on other types of cancers. Learn more here.

More good news comes from British scientists who have discovered 17 genes for diagnosing prostate cancer, reports dailymail.co.uk. Combined with the six genes already known to be linked to prostate cancer, there are now 23 genes that can be screened through a spit or blood test. Find more information about the research and what it means for diagnosis and treatment of prostate cancer here.

The not-so-good news reported this month is the increase in lung cancer among non-smokers — especially women. An in depth look at this growing issue can be found at theguardian.com here.

The ups and downs of cancer research news can be stressful for anyone, so to alleviate that stress, let’s all stay informed, and maybe take to our yoga mats. Until next month, namaste.

Notable News: Chemobrain

Sometimes the most notable information isn’t the latest research or current news story. Sometimes what is most notable is what is most pertinent to patients and survivors. So, this month when a survivor shared her struggle with “chemobrain”, it seemed like something worth looking into. Chemobrain, also called chemofog, is something cancer survivors have described for decades, says cancer.gov. For months, or sometimes years after treatment, survivors find that they struggle with their memory, paying attention, and processing information. Labeled chemobrain because so many of the survivors had chemotherapy, the actual cause isn’t completely known. For many years, patients who complained about chemobrain were dismissed, but now, the condition is widely acknowledged by the medical community. The cognitive issues can be associated with treatment of many types of cancer, but much of the research is focused on breast cancer survivors. Studies have shown that 17 percent to 75 percent of breast cancer survivors showed varying forms of chemo brain from six month to 20 years after treatment. Further research is being done to understand why some do and some don’t get chemobrain and what actually causes the cognitive issues. Chemobrain is for real; survivors who struggle with it, know that for sure. More information about chemobrain can be found here, and a top ten list of what survivors want you to know about chemobrain can be found here.

Chemobrain isn’t the only thing survivors need to consider after treatment. They need to stay healthy to lower their risk of recurrence or of getting another form of cancer. According to cdc.gov, follow-up care as ordered by your doctor is critical, but so is making healthy choices. Healthy choices include quitting smoking and/or avoiding second-hand smoke, limiting alcohol consumption, protecting your skin, eating fruits and vegetables, maintaining a healthy weight, staying active, and getting a flu shot every year. More resources for healthy living after cancer can be found here.

Healthy living, research continues to show, is also critical in preventing cancer. Researchers have found a direct link between sugary drinks and the accelerated growth of tumors in colorectal cancer, reports medicalnewstoday.com. The research, done on mice, will need to be expanded before the findings can be applied to humans, but the research does suggest that consuming sugary drinks can reduce the time it takes for cancer to form. More about the study can be found here.

While you may not have been able to avoid it in the news, there is something else you might want to avoid in order to prevent cancer, reports komonews.com. A study shows that chemicals, found in the weed killer Roundup, increase the risk of Non-Hodgkin Lymphoma by 41 percent. That makes the link between the weed killer and cancer stronger than was previously believed. The studies concerning Roundup and cancer continue, and more information can be found here.

There are some things about cancer that we may never understand, such as who will or won’t get chemobrain, but research continues to provide information about ways to prevent cancer, ways to live well after treatment, and ways to lower the risk of recurrence, and that is information that helps and empowers us all.

Notable News – December 2018

Here we are on the cusp of another trip around the sun, and we have the opportunity to look forward to what the new year may bring. According to cancer.gov and cdc.gov, statistics found here and here, are encouraging when it comes to cancer survival rates. The number of cancer survivors in the United States is expected to reach 20.3 million by 2026. That’s good news for the 38.4 percent of men and women in the US that will receive a cancer diagnosis at some point in their lifetimes. Of course, surviving cancer can be costly. Expenditures for cancer care, which were $147.3 billion in 2017, are expected to increase in the coming years thanks to factors such as a population that is aging and new and costlier treatments which are implemented as standards of care. While cancer care is expensive, it seems to be effective. The overall cancer death rate has been steadily declining in the US since the 1990s. In fact, from 1991 to 2015, the overall cancer death rate fell 26 percent. According to cdc.gov, by 2020 the cancer death rates are expected to drop the most for prostate cancer, colorectal cancer, lung cancer, female breast cancer, oral cancers, cervical cancers, and melanoma. With the death rate falling and the survivor rate increasing it’s clear that, over the past several years, progress has been made to effectively prevent and treat the disease. Fortunately, it looks like 2019 will follow that trend.

There are two promising cancer treatment developments this month, reports medicalnewstoday.com. The first one helps prevent the spread of cancer after surgery. A spray-on gel being developed could help stop the recurrence and spread of cancer tumors after surgery when it is applied to the surgery site. The gel is full of drugs that activate the immune system to prevent the return of the cancer. Testing done on mice has been promising. It prevented the recurrence of cancer at the surgery site and prevented tumors from forming in other areas of the body. You can find more details about the promising gel here.

The second development is an exciting combination of medications that may prevent tumor growth. A couple of years ago, researchers in Switzerland figured out that by combining metformin, a drug used to treat diabetes, with syrosingopine, a blood pressure drug, they could prevent cancer tumors from growing. The combination of the two drugs kills the cancer cells by cutting off their energy supply. You can learn more about how this dynamic drug duo works together to sock it to cancer here.

There’s also good news regarding breast cancer this month, reports standard.co.uk. This is really good news because it gives hope to women with one of the most aggressive forms of breast cancer. There aren’t many treatment options for triple negative breast cancer, but targeted antibody therapies might change that. Triple negative breast cancer does not respond to hormone treatment so patients have to be treated with surgery, chemotherapy, and radiation. The targeted antibody therapy would activate the patient’s immune system to fight the tumor. More about this exciting and developing treatment can be found here.

Of course, the best news of all comes when the cancer is no longer detectable, and that’s exactly what happened for a Texas girl this month, reports abc7chicago.com. The 11 year old had a rare and inoperable brain tumor, and she went through weeks of radiation. The radiation can stabilize or shrink the tumor and is the only course of treatment, but there is no cure. Inexplicably, the girl’s scans revealed that the tumor was no longer visible. While doctors call this case extraordinary, they say the long-term prognosis has not changed, and the tumor will likely grow back. In the mean time, the family says they prayed for a miracle and got it. More about this remarkable story, and a video, can be found here.

As we ring in 2019, let’s hope for more encouraging research and remarkable stories, and a day when all cancers disappear.

Notable News: October 2018

How tall are you? Do you eat breakfast cereal? What’s your blood pressure? Oh, and, moms, how old were you when you had babies? The answers to these questions just might be an indicator of your cancer risk. Sounds strange, doesn’t it? Well, if October’s Notable News teaches us anything, it’s that strange is not so unusual, especially when it comes to cancer risks.

The mysterious workings of the human body continue to offer up surprises, and appropriately enough for October, the latest surprise is about breast cancer, according to medicalexpress.com. For some time, scientists have known that women who have babies before the age of 30 have a reduced risk of getting breast cancer later in life, but now they know the specific week in which the risk reduction occurs. Women who have babies after 34 weeks averaged a 13.6 percent lower risk of developing breast cancer than did women who had no children. The risk reduction if the pregnancy ended just one week earlier was only 2.4 percent. Researchers don’t yet know what magic happens in the 34th week, but they do know that women must be under the age of 30 to benefit from it. More information can be found here.

While we’re on the subject of breast cancer, let’s talk about men because they get breast cancer, too. As Patient Empowerment Network blogger and breast cancer survivor Marie Ennis-O’Connor noted in her October 19 post, Beyond Pink: The Other Side of Breast Cancer Awareness and Lessons We’ve Learned From Each Other, breast cancer is not gender specific. While men make up less than one percent of all breast cancer occurrences, says breastcancer.org, an estimated 2,550 men in the United States have been or will be diagnosed this year. And because men are not routinely screened for breast cancer, they tend to be diagnosed when the disease is more advanced; therefore, it’s important for men to know the risk factors, which can be found here. While breast cancer awareness still focuses mainly on women, more attention is beginning to shift toward men, even making it’s way to primetime television. The series premiere of the new ABC drama A Million Little Things introduces a main male character who is a breast cancer survivor. More information about symptoms, diagnosis, and treatment of breast cancer in men can be found here. Please, take the time to find out if you, or the men you love, have any of the risk factors.

There’s a new risk factor to be mindful of…your height. That’s right. Your height. As reported by the guardian.com, the taller people among us are more likely to get cancer simply because they have more cells in their bodies. More cells means more opportunity for mutation. Apparently, it’s true for dogs, too. Bigger dogs, bigger risks. In humans, height seemed to cause an increased risk for 18 out of 23 cancers, including melanoma, which had a stronger link to height than researchers expected. Since there’s not much you can do about your height, researchers suggest that you focus on other risk factors instead, by maintaining a healthy weight and not smoking. Learn more about how height affects your cancer risk here.

You might want to consider breakfast cereal, too, reports freep.com. There is a chemical called glyphosate, the active ingredient in the weed killer, Roundup, that is showing up in products that are made with “conventionally grown” oats, which includes a lot of breakfast cereals. The International Agency for Research on Cancer says glyphosate is probably carcinogenic for humans, but Monsanto, the maker of Roundup, maintains the product is safe. While some experts say the information isn’t cause for hysteria, it is a good idea to pay attention to where your food comes from and what might be affecting it. You can find more about the glyphosate content in foods and which foods are affected here. It’s best to stay informed about the potential risks and use your best judgement.

The same holds true for those of you taking blood pressure medication. medicalexpress.com reports that some blood pressure medications might be linked to an increased lung cancer risk. The drugs are angiotensin converting enzyme inhibitor drugs (ACEIs), and the risk is elevated for people using the medication for five years or more. Overall, the risk is low, but is notable because of how widely ACEIs are prescribed. ACEIs are very effective at treating blood pressure and, if patients have concerns about any potential cancer risks, they should consider the risks and benefits with their doctors. There is still a lot more to be learned about ACEIs and their connection to lung cancer. You can find out more here.

Whether you’re a tall person who eats breakfast and has high blood pressure or you have some other strange cancer risk, the main thing to remember when it comes to risk factors is to stay informed, because when you have knowledge, you are empowered and that’s what it’s all about.

Notable News: September 2018

Since smoking is the leading cause of preventable disease and death worldwide, reports about it don’t usually contain good news, but this month they do. The International Association for the Study of Lung Cancer (IASLC) is convening in Toronto, Canada this week for the 19th World Conference on Lung Cancer #WCLC2018, and the importance of screening is being emphasized. Data coming out of the conference shows that CT screening reduces lung cancer deaths by 39% in women and 24% in men. Cdc.gov says the only recommended screening for lung cancer is low-dose computed tomography (also, low-dose CT scan or LDCT). Yearly lung cancer screenings are recommended for people who have a history of heavy smoking, smoke now or have quit in the past 15 years, and are between 55 and 80 years old. So, if you are at risk, make sure you are getting screened! Also, you can find the cdc.gov fact sheet about smoking here.

Another study shows that smoking might not remain the leading cause of preventable disease and death, but something else is going to take it’s place. Right now smoking is the leading cause of preventable cancer among women in the United Kingdom, but that is set to change, reports cnn.com. Thanks to a reduction in smoking and an increase in body weight, obesity will be the leading cause of cancer in women by 2043 if current trends continue. The news is particularly alarming because obesity can also cause some cancers, including breast cancer, to spread. Data collected between 1979 and 2014 was analyzed to determine the projections. Campaigns highlighting smoking risks are credited with the reduction in smoking-related cancers, and researchers are suggesting similar campaigns about the risk of obesity be implemented. More information can be found here. These findings aren’t unique to the UK; this report from November 2017 shows similar trends in the United States.

Obese or not, the quality of your food can increase your risk for cancer, reports medicalnewstoday.com. A study done in Paris shows that regular consumption of food low in nutritional value increases cancer risk. Of the 471,495 participants in the study, 49,794 had been diagnosed with cancer. More specifically, the findings showed men had an increased risk for colorectal cancer, cancer of the upper aerodigestive tract and stomach, and lung cancer. Women showed an increased risk for liver cancer and postmenopausal breast cancer. The research is being used to support the enforcement of a food-labeling system that would clearly state nutritional value of products. Learn more about the study and the food-labeling system here.

More good news comes this month in the form of new information. A study reported in cancer.gov reveals that cancer of the appendix, while usually given the same chemotherapy treatments, is actually quite different from colorectal cancer and other gastrointestinal cancers. The study also showed that the type of gene mutations present in appendiceal cancers could serve as an indicator for a patient’s prognosis. While the study isn’t likely to change practice yet, the information does provide helpful information about a rare cancer, and it indicates a need to develop treatments based on each specific cancer subtype. Much more detailed and technical information about the study findings and appendiceal cancers can be found here.

Finally, there are a couple of stories that happened this month that are worth sharing because they emphasize the poignancy of National Childhood Cancer Awareness Month in a way that little else could. The first is a love story about a couple that recently got married on the grounds of St. Jude’s Children’s Research Hospital. The bride and groom are both childhood cancer survivors who met at St. Jude’s while undergoing treatment 25 years ago. They lost touch over the years, but they were reunited when they both accepted jobs at St. Jude’s, and they rekindled their childhood friendship. Their friendship blossomed into love, and this couple of survivors chose September 1, the first day of Childhood Cancer Awareness Month, as their special day. Read more about the couple’s big day here. Bonus: there’s a video!

The second story is a different kind of love story. It’s about two-year-old Brody Allen. Brody has terminal brain cancer, and he loves Christmas. Brody isn’t expected to make it to Christmas this year so his parents decided to celebrate Christmas early. They put up a tree, and they put up outdoor decorations. Then, their neighbors started to decorate, too. Soon, the whole town was in on it and, earlier this week, Brody’s hometown put on a full-on, life-size Christmas parade in his honor, complete with super heroes and Santa Claus. You can read more about Brody here and see clips from his parade here. Merry Christmas, Brody.

Notable News: August 2018

The death of legendary singer Aretha Franklin received a lot of attention this month, but the cancer that killed her is in need of more awareness, say experts in a huffingtonpost.com article. The five year survival rate for pancreatic cancer is a very low eight percent. The disease often has no symptoms in the early stages, spreads early, is resistant to treatment, affects vital functions and, despite being thought of as rare, is increasing in frequency. However, there is some promising new research in the detection of pancreatic cancer (you’ll read about it in the next paragraph). Heightened awareness, funding, and research are needed to help combat this deadly disease. You can start by learning more here and, in case you missed it, you can find this month’s profile in which Alison Greenhill tells the story of her late husband’s experience with pancreatic cancer here.

The promising news is that a blood test could offer early screening for pancreatic and other cancers, according to research reported by dailymail.co.uk. In one study, scientists discovered that they can detect 95 percent of cancers through one blood test thanks to a protein produced by malaria parasites. When ten cancer cells were exposed to the protein, nine of them successfully attached to it. The test can also detect the cancers at any stage and help identify the aggressiveness of the disease. Among the cancers the test can detect are liver and pancreatic. Pancreatic cancer tends to have a low survival rate because it is often not found until the late stages of the disease. This blood test could allow for earlier detection. More can be learned about the potentially life-saving test here.

Another blood test has been found to detect melanoma with an 80 percent accuracy rate, says sciencealert.com. Caught early, the melanoma survival rate is 95 percent, but if it’s not detected early, chances for survival are below fifty percent. The test works by detecting antibodies that the body produces when melanoma forms. Currently, melanoma is detected through biopsies which are invasive and have a slightly lower accuracy rate than the blood test. The researchers hope to take the test to clinical trial and ultimately hope it will be used to detect the disease prior to biopsy in high-risk patients: those with fair skin, a lot of moles, and/or a family history of melanoma. More about this blood test can be found here. There is also a better way to determine which melanoma patients may benefit from immunotherapy. You can learn about that at axios.com here.

Another immunotherapy update comes from a recent study that may offer new insight into immunotherapy treatments, says geekwire.com. While immunotherapy has been a game-changer in treatment for many cancer patients, it doesn’t work at all for others and it can also come with some life-threatening side effects. Researchers set out to better understand the therapies and discovered how the components talk to each other in a process called signaling. It appears that the speed and strength of the signaling affect how the body responds to the treatment. It is the difference in the signaling that may help researchers find a way to reduce or eliminate the dangerous side effects and may also lead to making the treatments more effective. More information about this promising research can be found here.

As important as treatment is, keeping on top of when to be screened can be crucial to successful diagnosis and treatment. There are now more cervical cancer screening options for women aged 30 to 65, and you can learn about those at cnn.com here.

With all the positive research and advances in detection and treatment, it’s important to be aware that not all cancer patients have equal access to the best healthcare. It turns out that the disparities in minority health that we told you about here during National Minority Health month also apply to children. African American and Latino children are more likely to die from cancer, reports npr.org. Race and socio-economic status are factors. A comprehensive look at the research about the inequities in healthcare and survival rates for minority children can be found here.

Hopefully, the healthcare gap and survival rate can be narrowed because a new study shows that life is pretty good for most patients and survivors. The majority of current and former cancer patients who are 50 or older are happy, reports sciencedaily.com. The study showed that two-thirds of cancer patients fit the researchers description of complete mental health which was characterized by high levels of social and psychological well-being and being happy and/or satisfied with their daily lives. The cancer survivors were even happier with three-quarters of them meeting the complete mental health criteria. Learn more about this very happy study here.

Notable News – July 2018

There is some seriously risky business being reported in July. Meal times, diabetes, and bitter-taste sensitivity are all now being linked to a higher risk of cancer. Not to mention what researchers say the risks of complementary medicines might be.

There was another significant risk factor recently revealed, says dailymail.co.uk. A study of 20 million people conducted by Oxford University found that having diabetes increases your risk of cancer. Women with diabetes were 27 percent more likely to develop cancer and men were 19 percent more likely. The study, which included both type 1 and type 2 diabetes, showed that women with diabetes were more likely to develop leukemia and kidney, oral and stomach cancers. The men had a higher risk for developing liver cancer. Diabetes also puts people at risk for heart attacks, strokes, and dementia. You can read more about the findings and diabetes risks here.

Still another new cancer risk factor for women was reported by sciencedaily.com. It was discovered that women who have a high sensitivity to bitter taste also have a high cancer risk. The study tracked the diet, lifestyle, and health of 5,500 British women for 20 years. The women were divided into three categories of bitter sensitivity: super-tasters, tasters and non-tasters. The super-tasters had a 58 percent greater risk and the tasters had a 40 percent greater risk of developing cancer than the non-tasters. Researchers hypothesized that lower vegetable consumption would be a cause for the significant increase in cancer risk for the tasters and super-tasters, but their theory was not proved by the research. Researchers continue to suspect a relationship between diet and cancer risk and hope to further study the overall diet of the tasters and super-tasters to try to determine the connection. More details about the study can be found here.

Alternative medicine may not put you at risk for cancer, but it may increase your risk of dying from it, reports nbcnews.com. A study done by the Yale Cancer Center found that treatments commonly referred to as complementary medicine, including the use of herbs and homeopathy, aren’t harmful when used with standard, conventional cancer treatments, but if the complementary treatments are used instead of the conventional treatments, patients are twice as likely to die from their cancer. The patients who were most likely to use the alternative treatments were young, affluent women and the researchers noted that doctors should use the information from the study to make sure they are meeting the needs of their patients who may turn down standard treatment in favor of alternative treatments. Researchers also acknowledged that alternative treatments such as yoga, acupuncture, and meditation can help to improve a patients quality of life and if they make the patient feel better they should be encouraged to use complementary medicine in addition to conventional treatments. You can read more here.

Make sure you aren’t at risk of missing out on the latest and most compelling cancer-related information. You can find it all here at powerfulpatients.org.